AXL and renal cell carcinoma: In vivo xenograft studies, MAb173 reduced tumor growth, increased tumor cell apoptosis, and markedly decreased AXL protein levels in tumors. hMAb173 significantly induced RCC cell apoptosis in histoculture and inhibited the growth of RCC tumor in vivo by 78%.